Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03765619 · ClinicalTrials.gov registry record · Early Phase 1
Postoperative Aspirin and Ankle Fracture Healing
A Early Phase 1 study of Ankle Fractures, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 500
- Enrollment target
- 1
- Study location
NCT03765619: Completed Early Phase 1 study of Ankle Fractures, sponsored by University of Alabama at Birmingham.
NCT03765619 is a Early Phase 1 study of Ankle Fractures that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 500 participants, above the 212-participant average among 12 other Ankle Fractures trials with a reported enrollment target (136% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03765619, a Early Phase 1 study of Ankle Fractures, has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 500 participants
- Enrollment target
- 1
- Study location
Study Summary
This study aims to identify if postoperative aspirin use leads to a delay in fracture healing. NSAIDs have long been avoided in the management of fractures, due to the belief that they may impair fracture healing. As aspirin is frequently prescribed for long-term management of various medical conditions, it is worth understanding if continuing to take aspirin during the process of fracture healing has a clinically significant effect on the rate of fracture healing.
Primary Outcome
Union Rates of Ankle Fractures postoperatively as assessed clinically and radiographically. X-rays will be taken at each postoperative visit.
Conditions Studied
Interventions
- DRUG Aspirin
Study Locations (1)
Alabama
- UAB Highland Hospital - Birmingham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2019-06-12 |
| Est. Completion | 2019-11-26 |
| Phase | Early Phase 1 |
What the finished NCT03765619 record still lists
NCT03765619 is an interventional study that assigns participants to a tested intervention. The registered 500 participants enrollment target is mid-sized for trials with a published cap, above the 212-participant average among 12 other Ankle Fractures trials with a reported enrollment target (136% higher).
The record links to 1 condition, with Ankle Fractures appearing as the primary indexed condition, and to 1 intervention - of which Aspirin is the first listed.
NCT03765619 reports a single indexed study location in Alabama.
Frequently Asked Questions
What is clinical trial NCT03765619 about?
NCT03765619 is a clinical study titled "Postoperative Aspirin and Ankle Fracture Healing". This study aims to identify if postoperative aspirin use leads to a delay in fracture healing. NSAIDs have long been avoided in the management of fractures, due to the belief that they may impair fracture healing. As aspirin is frequently prescribed for long-term management of various medical condit...
What is the current status of trial NCT03765619?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 500 participants. The study started on 2019-06-12. Estimated completion is 2019-11-26.
What conditions does trial NCT03765619 study?
This clinical trial studies the following conditions: Ankle Fractures.
What interventions are being tested in trial NCT03765619?
The interventions under investigation include: Aspirin (DRUG).
Who is sponsoring clinical trial NCT03765619?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03765619 being conducted?
This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Ankle Fractures
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03765619's enrollment target sits among peer trials
500 2nd of 12 the highest of 12 other Ankle Fractures trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Ankle Fractures trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Local Multimodal Injection Versus Regional Anesthesia in Controlling Pain for Treating Rotational Ankle Fractures
ACTIVE NOT RECRUITING · Early Phase 1
-
Neuromuscular Electrical Stimulation in Foot and Ankle Surgery
RECRUITING · NA
-
Fibulink Syndesmosis Repair System With Early Full-Weight Bearing
RECRUITING · NA
-
Efficacy and Clinical Feasibility of the Ankle Muscle Power (AMP) Program for Return to Duty After an Ankle Fracture
RECRUITING · NA
-
Correlation Between Intraoperative Tourniquet Use and Limb pH, Functional Measures and Patient-reported Outcomes After Ankle Fracture Surgery
RECRUITING · NA
-
Simplified Post Op Rehabilitation for Ankle and Pilon Fractures
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001230 · 500 participants
Host Response to Infection and Treatment in Filarial Diseases
- NCT00001529 · 500 participants
Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives
- NCT00697411 · 500 participants
Study of Selected X-Linked Disorders: Aicardi Syndrome
- NCT00903110 · 500 participants
Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI